Overview
Massimo Cesareo practices in Rome, Italy. Mr. Cesareo is highly rated in 6 conditions, according to our data. His top areas of expertise are Ganglion Cyst, Glaucoma, Ocular Hypertension (OHT), Optic Nerve Atrophy, and Vitrectomy.
His clinical research consists of co-authoring 65 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Ganglion CystMr. Cesareo isDistinguished. Learn about Ganglion Cyst.
- Advanced
- GlaucomaMr. Cesareo isAdvanced. Learn about Glaucoma.
- Ocular Hypertension (OHT)Mr. Cesareo isAdvanced. Learn about Ocular Hypertension (OHT).
- Optic Nerve AtrophyMr. Cesareo isAdvanced. Learn about Optic Nerve Atrophy.
- Pigment-Dispersion SyndromeMr. Cesareo isAdvanced. Learn about Pigment-Dispersion Syndrome.
- Retinopathy ArterioscleroticMr. Cesareo isAdvanced. Learn about Retinopathy Arteriosclerotic.
- Experienced
- AngioedemaMr. Cesareo isExperienced. Learn about Angioedema.
- Cerebral HypoxiaMr. Cesareo isExperienced. Learn about Cerebral Hypoxia.
- Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
- Hereditary AngioedemaMr. Cesareo isExperienced. Learn about Hereditary Angioedema.
- HivesMr. Cesareo isExperienced. Learn about Hives.
- Late-Onset Retinal DegenerationMr. Cesareo isExperienced. Learn about Late-Onset Retinal Degeneration.